Dr. Puri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Avenue
J2-3
Cleveland, OH 44106Phone+1 216-444-2913
Education & Training
- The University of Adelaide Faculty of Health SciencesClass of 2002
Certifications & Licensure
- OH State Medical License 2018 - 2020
Clinical Trials
- Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment Start of enrollment: 2023 Oct 05
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Chronic Kidney Disease Predisposes to Acute Congestive Heart Failure, Cardiogenic Shock, and Mortality in Patients Undergoing Percutaneous Coronary Intervention.Meghana Iyer, Khaled Ziada, Leslie Cho, Jacqueline Tamis-Holland, Umesh Khot
The American Journal of Cardiology. 2024-12-15 - 1 citationsDecreasing pacemaker implantation rates with Evolut supra-annular transcatheter aortic valves in a large real-world registry.James E Harvey, Rishi Puri, Kendra J Grubb, Steven J Yakubov, Paul D Mahoney
Cardiovascular Revascularization Medicine. 2024-12-01 - Contemporary Outcomes of TAVR Using a Balloon-Expandable Valve in Patients With Severe Mitral Stenosis: Insights From the Transcatheter Valve Therapies Registry.Anirudh Kumar, Imran N Ahmad, James D Flaherty, Vinayak Nagaraja, Chetan P Huded
Circulation. Cardiovascular Interventions. 2024-11-22
Journal Articles
- Original Investigation Effect of Evolocumab on Coronary Plaque CompositionSteven E Nissen, Ransi Somaratne, Rishi Puri, Christie M Ballantyne, ScienceDirect
- Editorial Comment Unraveling the Cardiovascular PROSPECTs of Patients with Prediabetes∗Rishi Puri, MD, ScienceDirect
Press Mentions
- NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients with Significant CADSeptember 1st, 2024
- BioVentrix Raises $48.5m for Transcatheter Ventricular Enhancement System PMAApril 14th, 2023
- New Study Demonstrates Accurate Measurement of Left Ventricular Function Following Treatment with BioVentrix Revivent TC® TherapyMarch 15th, 2023
- Join now to see all
Other Languages
- French, Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: